Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand β network effects sharpen as coverage grows.
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine is a research paper published in JCI Insight (2023). On theSindex it has a DataRank of 0. It has been cited 34 times.
N/A
Scored on demand from live citation data
Open Access34 citations
Cite:
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
βΊMethodology & internals
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Pending
FAIR Checklist
Context only (not used in score)Findable (1/2)
- Has DOI
Accessible (1/2)
- Open Access
Interoperable (0/2)
Reusable (0/3)
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Run a calibrated FAIR evaluation for this paper β
We only score data papers we can read in full β never from an abstract alone.
Authors (25)
Related Papers (10)
Trained immunity, tolerance, priming and differentiation: distinct immunological processes0.961DataRank Β· unranked
N/A
Nature Immunology(2020)
co-cited
10.1038/s41590-020-00845-6Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?0.756DataRank Β· unranked
N/A
Trends in Immunology(2020)
co-cited
10.1016/j.it.2020.04.001SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses15.6DataRank Β· unranked
N/A
Nature(2021)
co-cited
10.1038/s41586-021-03738-2The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination4.1DataRank Β· unranked
N/A
Cell(2021)
co-cited
10.1016/j.cell.2021.05.039Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial1.7DataRank Β· unranked
N/A
The Lancet Infectious Diseases(2021)
co-cited
10.1016/s1473-3099(21)00332-7